Insider Trading activities at Ionis Pharmaceuticals Inc (IONS) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ionis Pharmaceuticals Inc (IONS) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ionis Pharmaceuticals Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 874015.

Total stock buying since 2015: $477,900.
Total stock sales since 2015: $220,707,715.
Total stock option exercises since 2015: $87,022,179.


27 insiders reported insider trading activities at Ionis Pharmaceuticals Inc (IONS):
Insider trading activities of Castleman Breaux
Insider trading activities of Devers Shannon L.
Insider trading activities of Reikes Peter N
Insider trading activities of Crooke Stanley T
Insider trading activities of Herman Joan E
Insider trading activities of O'neil Patrick R.
Insider trading activities of Loscalzo Joseph
Insider trading activities of Jenne Kyle
Insider trading activities of Hayden Michael R
Insider trading activities of Diaz Allene M.
Insider trading activities of Boyce Sarah
Insider trading activities of Schneider Eugene
Insider trading activities of Klein Joseph Iii
Insider trading activities of Birchler Brian
Insider trading activities of Monia Brett P
Insider trading activities of Yang Michael J.
Insider trading activities of Mcdevitt Damien
Insider trading activities of Bennett C Frank
Insider trading activities of Muto Frederick T
Insider trading activities of Cadoret-manier Onaiza
Insider trading activities of Parshall B Lynne
Insider trading activities of Wender Joseph H
Insider trading activities of Hougen Elizabeth L
Insider trading activities of Swayze Eric
Insider trading activities of Berthelsen Spencer R
Insider trading activities of Geary Richard S
Insider trading activities of Baroldi Joseph

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Ionis Pharmaceuticals Inc (IONS).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 15,000 $477,900 993,870 $54,623,894 1,107,680 $26,972,189
2024 0 $0 216,854 $10,417,483 306,713 $1,690,800
2023 0 $0 480,350 $22,469,267 633,770 $17,444,961
2022 0 $0 9,319 $373,594 272,987 $291,150
2021 0 $0 128,563 $7,483,627 277,627 $139,500
2020 0 $0 435,149 $22,468,509 430,271 $8,790,881
2019 0 $0 528,804 $37,414,368 631,186 $18,611,478
2018 0 $0 237,729 $11,778,492 331,168 $2,959,654
2017 0 $0 327,296 $17,001,714 394,558 $3,417,846
2016 0 $0 240,936 $9,522,537 302,772 $2,241,037
2015 0 $0 422,957 $27,154,230 458,215 $4,462,683


Table 3. Detailed insider trading at Ionis Pharmaceuticals Inc (IONS) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2024-01-16 Monia Brett P (Chief Executive Officer) Option Ex 68,084 .00 0
2024-01-16 Geary Richard S (EVP, Chief Development Officer) Option Ex 19,852 .00 0
2024-01-16 Hougen Elizabeth L (EVP, Finance & CFO) Option Ex 22,487 .00 0
2024-01-16 Bennett C Frank (EVP, Chief Scientific Officer) Option Ex 18,314 .00 0
2024-01-12 Schneider Eugene (EVP, Chf Clinical Develop Ofcr) Sale 8,000 53.50 428,000
2024-01-12 Schneider Eugene (EVP, Chf Clinical Develop Ofcr) Option Ex 8,000 32.60 260,800
2023-12-28 Birchler Brian (EVP, Corp and Development Ops) Option Ex 11,500 47.34 544,410
2023-12-28 Swayze Eric (EVP Research) Sale 27,100 50.19 1,360,094
2023-12-28 Swayze Eric (EVP Research) Option Ex 27,100 47.34 1,282,914
2023-12-28 Hougen Elizabeth L (EVP, Finance & CFO) Option Ex 45,225 47.34 2,140,951
2023-12-28 Parshall B Lynne (Director) Sale 42,525 50.19 2,134,244
2023-12-28 Parshall B Lynne (Director) Option Ex 42,525 47.34 2,013,133
2023-12-27 Parshall B Lynne (Director) Sale 50,000 50.23 2,511,500
2023-12-27 Parshall B Lynne (Director) Option Ex 50,000 47.34 2,367,000
2023-12-26 Schneider Eugene (EVP, Chf Clinical Develop Ofcr) Sale 25,000 51.46 1,286,575
2023-12-26 Schneider Eugene (EVP, Chf Clinical Develop Ofcr) Option Ex 25,000 47.34 1,183,500
2023-12-26 O'neil Patrick R. (EVP CLO & General Counsel) Sale 20,825 51.46 1,071,716
2023-12-26 O'neil Patrick R. (EVP CLO & General Counsel) Option Ex 20,825 47.34 985,855
2023-12-26 Parshall B Lynne (Director) Sale 25,113 51.46 1,292,390
2023-12-26 Parshall B Lynne (Director) Option Ex 25,113 47.34 1,188,849
2023-12-21 Monia Brett P (Chief Executive Officer) Sale 17,500 49.29 862,575
2023-12-21 Monia Brett P (Chief Executive Officer) Option Ex 17,500 47.34 828,450
2023-12-21 Geary Richard S (EVP, Chief Development Officer) Sale 4,112 49.29 202,680
2023-12-21 Geary Richard S (EVP, Chief Development Officer) Option Ex 4,112 47.34 194,662
2023-12-21 Bennett C Frank (EVP, Chief Scientific Officer) Sale 16,113 49.29 794,209
2023-12-21 Bennett C Frank (EVP, Chief Scientific Officer) Option Ex 16,113 47.34 762,789
2023-12-20 Monia Brett P (Chief Executive Officer) Sale 6,500 49.64 322,640
2023-12-20 Monia Brett P (Chief Executive Officer) Option Ex 6,500 47.34 307,710
2023-12-20 Geary Richard S (EVP, Chief Development Officer) Sale 6,500 49.64 322,640
2023-12-20 Geary Richard S (EVP, Chief Development Officer) Option Ex 6,500 47.34 307,710
2023-12-20 Bennett C Frank (EVP, Chief Scientific Officer) Sale 6,500 49.64 322,640
2023-12-20 Bennett C Frank (EVP, Chief Scientific Officer) Option Ex 6,500 47.34 307,710
2023-12-14 Monia Brett P (Chief Executive Officer) Sale 24,000 49.70 1,192,800
2023-12-14 Monia Brett P (Chief Executive Officer) Option Ex 24,000 47.34 1,136,160
2023-12-14 Geary Richard S (EVP, Chief Development Officer) Sale 10,613 49.70 527,466
2023-12-14 Geary Richard S (EVP, Chief Development Officer) Option Ex 10,613 47.34 502,419
2023-12-14 Bennett C Frank (EVP, Chief Scientific Officer) Sale 22,612 49.70 1,123,816
2023-12-14 Bennett C Frank (EVP, Chief Scientific Officer) Option Ex 22,612 47.34 1,070,452
2023-10-17 Swayze Eric (EVP Research) Sale 52 47.95 2,493
2023-10-16 Swayze Eric (EVP Research) Option Ex 125 .00 0
2023-10-12 Monia Brett P (Chief Executive Officer) Sale 3,770 46.00 173,420
2023-09-28 Bennett C Frank (EVP, Chief Scientific Officer) Sale 4,460 46.50 207,390
2023-09-26 Klein Joseph Iii (Director) Sale 2,000 45.13 90,254
2023-09-26 Parshall B Lynne (Director) Sale 10,000 45.13 451,270
2023-08-01 Diaz Allene M. (Director) Sale 657 41.05 26,969
2023-07-18 Klein Joseph Iii (Director) Sale 3,555 42.00 149,310
2023-07-17 Diaz Allene M. (Director) Option Ex 5,333 .00 0
2023-07-17 Hayden Michael R (Director) Option Ex 7,110 .00 0
2023-07-17 Loscalzo Joseph (Director) Option Ex 7,110 .00 0
2023-07-17 Herman Joan E (Director) Option Ex 7,110 .00 0
2023-07-17 Klein Joseph Iii (Director) Option Ex 7,110 .00 0
2023-07-17 Berthelsen Spencer R (Director) Option Ex 7,110 .00 0
2023-07-17 Parshall B Lynne (Director) Option Ex 7,110 .00 0
2023-07-17 Wender Joseph H (Director) Option Ex 7,110 .00 0
2023-07-07 Monia Brett P (Chief Executive Officer) Sale 18,650 42.25 787,962
2023-06-20 Berthelsen Spencer R (Director) Option Ex 11,250 28.47 320,287
2023-06-12 Herman Joan E (Director) Option Ex 3,555 .00 0
2023-05-24 O'neil Patrick R. (EVP CLO & General Counsel) Sale 1,527 41.70 63,675
2023-05-22 Monia Brett P (Chief Executive Officer) Sale 4,931 40.13 197,905
2023-04-18 Birchler Brian (EVP, Corp and Development Ops) Sale 672 36.50 24,529
2023-04-18 Baroldi Joseph (EVP, Chief Business Officer) Sale 3,880 36.50 141,631
2023-04-18 Cadoret-manier Onaiza (EVP, Chf GL Pdt Str & Oper Ofc) Sale 2,582 36.50 94,250
2023-04-17 Birchler Brian (EVP, Corp and Development Ops) Option Ex 1,875 .00 0
2023-04-17 Baroldi Joseph (EVP, Chief Business Officer) Option Ex 10,838 .00 0
2023-04-17 Cadoret-manier Onaiza (EVP, Chf GL Pdt Str & Oper Ofc) Option Ex 5,667 .00 0
2023-02-06 Schneider Eugene (EVP, Chf Clinical Develop Ofcr) Sale 1,413 40.67 57,463
2023-02-06 Cadoret-manier Onaiza (EVP, Chf GL Pdt Str & Oper Ofc) Sale 1,451 40.66 58,997
2023-02-06 Swayze Eric (EVP Research) Sale 1,815 40.79 74,032
2023-02-06 O'neil Patrick R. (EVP CLO & General Counsel) Sale 1,920 40.87 78,460
2023-02-06 Monia Brett P (Chief Executive Officer) Sale 24,651 40.69 1,003,147
2023-02-06 Geary Richard S (EVP, Chief Development Officer) Sale 1,920 40.66 78,071
2023-02-06 Hougen Elizabeth L (EVP, Finance & CFO) Sale 2,079 40.59 84,392
2023-02-06 Bennett C Frank (EVP, Chief Scientific Officer) Sale 1,813 40.57 73,560
2023-01-31 O'neil Patrick R. (EVP CLO & General Counsel) Sale 4,500 39.71 178,699
2023-01-30 O'neil Patrick R. (EVP CLO & General Counsel) Sale 4,500 39.42 177,372
2023-01-18 Schneider Eugene (EVP, Chf Clinical Develop Ofcr) Sale 4,752 39.57 188,050
2023-01-18 Baroldi Joseph (EVP, Chief Business Officer) Sale 375 39.79 14,920
2023-01-18 Cadoret-manier Onaiza (EVP, Chf GL Pdt Str & Oper Ofc) Sale 3,748 39.55 148,222
2023-01-18 Swayze Eric (EVP Research) Sale 5,631 39.74 223,798
2023-01-18 O'neil Patrick R. (EVP CLO & General Counsel) Sale 7,836 39.49 309,482
2023-01-18 Monia Brett P (Chief Executive Officer) Sale 25,066 39.49 989,956
2023-01-18 Geary Richard S (EVP, Chief Development Officer) Sale 7,873 39.57 311,526
2023-01-18 Hougen Elizabeth L (EVP, Finance & CFO) Sale 8,280 39.70 328,724
2023-01-18 Bennett C Frank (EVP, Chief Scientific Officer) Sale 6,978 38.89 271,353
2023-01-17 Schneider Eugene (EVP, Chf Clinical Develop Ofcr) Option Ex 13,046 .00 0
2023-01-17 Baroldi Joseph (EVP, Chief Business Officer) Option Ex 904 .00 0
2023-01-17 Cadoret-manier Onaiza (EVP, Chf GL Pdt Str & Oper Ofc) Option Ex 10,197 .00 0
2023-01-17 Swayze Eric (EVP Research) Option Ex 15,780 .00 0
2023-01-17 O'neil Patrick R. (EVP CLO & General Counsel) Option Ex 21,871 .00 0
2023-01-17 Monia Brett P (Chief Executive Officer) Option Ex 57,267 .00 0
2023-01-17 Geary Richard S (EVP, Chief Development Officer) Option Ex 21,983 .00 0
2023-01-17 Klein Joseph Iii (Director) Sale 2,000 40.00 80,000
2023-01-17 Hougen Elizabeth L (EVP, Finance & CFO) Option Ex 23,154 .00 0
2023-01-17 Bennett C Frank (EVP, Chief Scientific Officer) Option Ex 19,417 .00 0
2022-10-17 Schneider Eugene (EVP, Chf Clinical Develop Ofcr) Option Ex 416 .00 0
2022-10-17 Hayden Michael R (Director) Option Ex 1,777 .00 0
2022-09-08 Swayze Eric (EVP Research) Sale 460 44.55 20,493
2022-08-05 Swayze Eric (EVP Research) Sale 1 45.20 45
2022-07-15 Diaz Allene M. (Director) Option Ex 8,000 .00 0
2022-07-15 Hayden Michael R (Director) Option Ex 7,110 .00 0
2022-07-15 Loscalzo Joseph (Director) Option Ex 7,998 .00 0
2022-07-15 Herman Joan E (Director) Option Ex 7,110 .00 0
2022-07-15 Klein Joseph Iii (Director) Sale 1,333 38.26 51,000
2022-07-15 Klein Joseph Iii (Director) Option Ex 7,998 .00 0
2022-07-15 Muto Frederick T (Director) Option Ex 7,998 .00 0
2022-07-15 Berthelsen Spencer R (Director) Option Ex 7,998 .00 0
2022-07-15 Parshall B Lynne (Director) Option Ex 7,998 .00 0
2022-07-15 Wender Joseph H (Director) Option Ex 7,998 .00 0
2022-07-01 Muto Frederick T (Director) Option Ex 11,250 12.94 145,575
2022-06-10 Herman Joan E (Director) Option Ex 3,555 .00 0
2022-06-07 Berthelsen Spencer R (Director) Option Ex 11,250 12.94 145,575
2022-04-21 Swayze Eric (EVP Research) Sale 378 44.15 16,688
2022-04-18 Cadoret-manier Onaiza (EVP, Chf Pdt Str & Oper Ofc) Option Ex 5,667 .00 0
2022-04-12 O'neil Patrick R. (EVP CLO & General Counsel) Sale 6,792 40.06 272,060
2022-04-01 Monia Brett P (Chief Executive Officer) Sale 355 37.49 13,308
2022-01-18 Schneider Eugene (EVP, Chf Clinical Develop Offc) Option Ex 10,400 .00 0
2022-01-18 Cadoret-manier Onaiza (EVP, Chf Corp Dev and Cml Offc) Option Ex 6,057 .00 0
2022-01-18 Swayze Eric (EVP Research) Option Ex 13,809 .00 0
2022-01-18 O'neil Patrick R. (EVP CLO & General Counsel) Option Ex 21,086 .00 0
2022-01-18 Monia Brett P (Chief Executive Officer) Option Ex 49,475 .00 0
2022-01-18 Geary Richard S (EVP, Chief Development Officer) Option Ex 21,391 .00 0
2022-01-18 Hougen Elizabeth L (EVP, Finance & CFO) Option Ex 22,050 .00 0
2022-01-18 Bennett C Frank (EVP, Chief Scientific Officer) Option Ex 18,842 .00 0
2022-01-18 Parshall B Lynne (Director) Option Ex 5,754 .00 0
2021-10-15 Schneider Eugene (EVP, Chf Clinical Develop Offc) Option Ex 417 .00 0
2021-10-15 Reikes Peter N (Director) Option Ex 1,777 .00 0
2021-10-15 Hayden Michael R (Director) Option Ex 1,777 .00 0
2021-07-15 Reikes Peter N (Director) Option Ex 7,111 .00 0
2021-07-15 Hayden Michael R (Director) Option Ex 7,111 .00 0
2021-07-15 Loscalzo Joseph (Director) Option Ex 8,666 .00 0
2021-07-15 Herman Joan E (Director) Option Ex 7,111 .00 0
2021-07-15 Klein Joseph Iii (Director) Sale 4,334 35.30 152,990
2021-07-15 Klein Joseph Iii (Director) Option Ex 8,666 .00 0
2021-07-15 Muto Frederick T (Director) Option Ex 8,666 .00 0
2021-07-15 Berthelsen Spencer R (Director) Option Ex 8,666 .00 0
2021-07-15 Parshall B Lynne (Director) Option Ex 8,000 .00 0
2021-07-15 Wender Joseph H (Director) Option Ex 8,666 .00 0
2021-06-15 Muto Frederick T (Director) Sale 15,000 36.63 549,495
2021-06-15 Muto Frederick T (Director) Option Ex 15,000 9.30 139,500
2021-04-15 Cadoret-manier Onaiza (Chief Corp Dev and Cml Officer) Option Ex 5,667 .00 0
2021-03-01 Monia Brett P (Chief Executive Officer) Sale 236 54.27 12,808
2021-01-26 Crooke Stanley T (Exec Chairman of the Board) Sale 28,333 63.73 1,805,803
2021-01-25 O'neil Patrick R. (EVP & General Counsel) Sale 5,324 63.50 338,074
2021-01-22 Crooke Stanley T (Exec Chairman of the Board) Sale 40,000 61.67 2,467,000
2021-01-21 Crooke Stanley T (Exec Chairman of the Board) Sale 35,000 61.09 2,138,150
2021-01-15 Schneider Eugene (EVP, Chf Clinical Develop Offc) Option Ex 7,503 .00 0
2021-01-15 Swayze Eric (EVP, Research) Option Ex 8,944 .00 0
2021-01-15 O'neil Patrick R. (EVP & General Counsel) Option Ex 16,504 .00 0
2021-01-15 Monia Brett P (Chief Executive Officer) Option Ex 34,823 .00 0
2021-01-15 Geary Richard S (EVP, Chief Development Offc) Option Ex 17,598 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of IONS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ionis Pharmaceuticals Inc (symbol IONS, CIK number 874015) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.